Notably, when Liu et al. profiled the immune cells within the tumor microenvironment of mice bearing CT-2A and GL261, they found that the percent of CD8+ T cells expressing the checkpoint molecules PD-1 and Lag-3 were significantly higher in CT-2A relative to GL261 [44]. The gene discussed is CD8A; the disease is neoplasm.